PENTOSTATIN Side Effects

7009027-7 | Acquired Oesophageal Web, Dyspepsia, Fatigue, Gastroenteritis Eosinophilic, No Therapeutic Response, Pancytopenia
on Sep 14, 2010 Male patient from UNITED STATES , 43 years of age, was diagnosed with hairy cell leukaemia and was treated with Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: acquired oesophageal web, dyspepsia, fatigue, gastroenteritis eosinophilic, no therapeutic response, pancytopenia. Pentostatin dosage: 4 Mg/m^2 Every Two Weeks, Intravenous. During the same period patient was treated with TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ), (DOLASETRON) (View (dolasetron) Review and (dolasetron) Label ).

6918102-4 | Febrile Neutropenia, Thrombocytopenia
Patient was taking Pentostatin (View Usage). Patient had the following side effects: febrile neutropenia, thrombocytopenia on Jul 30, 2010 from ITALY Additional patient health information: Male patient , 86 years of age, . Pentostatin dosage: 10 Mg Milligram(s).

6730188-9 | Abdominal Pain, Amnesia, Confusional State, Diffuse Large B-cell Lymphoma, Epstein-barr Virus Antibody Positive, Gastrointestinal Haemorrhage, Herpes Zoster, Lymphadenopathy, Malignant Neoplasm Progression
Adverse event was reported on May 06, 2010 by a Female patient taking Pentostatin (View Usage) (Dosage: ) was diagnosed with t-cell prolymphocytic leukaemia and. Location: UNITED STATES , 60 years of age, After Pentostatin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), amnesia, confusional state, diffuse large b-cell lymphoma, epstein-barr virus antibody positive, gastrointestinal haemorrhage, herpes zoster, lymphadenopathy, malignant neoplasm progression. Patient was hospitalized.

6376332-7 | Bone Marrow Disorder, Cachexia, Dysuria, Immunosuppression, Infection Protozoal, Microsporidia Infection, Pancytopenia, Toxoplasmosis
on Sep 18, 2009 Female patient from FRANCE , 72 years of age, was diagnosed with t-cell prolymphocytic leukaemia and was treated with Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow disorder, cachexia, dysuria, immunosuppression, infection protozoal, microsporidia infection, pancytopenia, toxoplasmosis. Pentostatin dosage: . During the same period patient was treated with ALEMTUZUMAB (View Alemtuzumab Review and Alemtuzumab Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), ALBENDAZOLE (View Albendazole Review and Albendazole Label ), SULFADIAZINE (View Sulfadiazine Review and Sulfadiazine Label ), PYRIMETHIAMINE (View Pyrimethiamine Review and Pyrimethiamine Label ).


6355084-0 | Bacteria Stool Identified, Dysuria, Immunosuppression, Microsporidia Infection, Pancytopenia
on Sep 01, 2009 Female patient from FRANCE , 72 years of age, was diagnosed with t-cell prolymphocytic leukaemia and was treated with Pentostatin (View Usage). Patient had the following side effects: bacteria stool identified, dysuria, immunosuppression, microsporidia infection, pancytopenia. Pentostatin dosage: . During the same period patient was treated with (ALEMTUZUMAB) (View (alemtuzumab) Review and (alemtuzumab) Label ), (ANTIBIOTICS) (View (antibiotics) Review and (antibiotics) Label ), (ALBENDAZOLE) (View (albendazole) Review and (albendazole) Label ), SULFADIAZINE (View Sulfadiazine Review and Sulfadiazine Label ), PYRIMETHAMINE TAB (View Pyrimethamine Tab Review and Pyrimethamine Tab Label ).

5873784-3 | Asthenia, Fatigue, Neutrophil Count Decreased
Patient was taking Pentostatin (View Usage). After Pentostatin was administered, patient had the following side effects: asthenia, fatigue, neutrophil count decreased on Sep 03, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 202.8 lb, . Pentostatin dosage: 8.6 Mg. During the same period patient was treated with RITUXIMAB (1700 Mg) (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (1300 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ).

5681009-7 | Aspiration Pleural Cavity Abnormal, Condition Aggravated, Coronary Artery Bypass, Diarrhoea, Hypoxia, Neutropenia, Oedema Peripheral, Pancytopenia, Pleural Effusion
Adverse event was reported on Mar 17, 2008 by a Male patient taking Pentostatin (View Usage) (Dosage: 7.24 Mg 3/wk Iv) . Location: UNITED STATES , 69 years of age, weighting 143.0 lb, Patient experienced the following unwanted or unexpected effects: aspiration pleural cavity abnormal, condition aggravated, coronary artery bypass (What is coronary artery bypass?), diarrhoea, hypoxia, neutropenia, oedema peripheral, pancytopenia, pleural effusion. During the same period patient was treated with CYTOXAN (108 Mg 3/wk Iv) (View Cytoxan Review and Cytoxan Label ), COMPAZINE (View Compazine Review and Compazine Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NIACIN (View Niacin Review and Niacin Label ), FEOSOL (View Feosol Review and Feosol Label ). Patient was hospitalized.

5663764-5 | Anaemia, Anaphylactic Reaction, Transfusion Reaction
on Mar 03, 2008 Male patient from UNITED STATES , 69 years of age, weighting 151.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Pentostatin (View Usage). Patient had the following side effects: anaemia, anaphylactic reaction, transfusion reaction. Pentostatin dosage: 7.24 Mg Q3w Iv. During the same period patient was treated with CYTOXAN (108 Mg Q3w Iv) (View Cytoxan Review and Cytoxan Label ), COMPAZINE /00013302/ (View Compazine /00013302/ Review and Compazine /00013302/ Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), RITUXAN (673 Mg Q3w Iv) (View Rituxan Review and Rituxan Label ), LIPITOR /01326101/ (View Lipitor /01326101/ Review and Lipitor /01326101/ Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

5597481-7 | Bacteraemia, Renal Failure Acute, Vision Blurred
on Jan 14, 2008 Female patient from UNITED STATES , 49 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Pentostatin (View Usage). After Pentostatin was administered, patient had the following side effects: bacteraemia, renal failure acute, vision blurred. Pentostatin dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXAN (View Rituxan Review and Rituxan Label ).

5449661-9 | Atrial Fibrillation, Atrial Flutter, Bacteraemia, Graft Versus Host Disease, Pulmonary Oedema, Respiratory Failure, Septic Shock
Patient was taking Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), atrial flutter, bacteraemia, graft versus host disease, pulmonary oedema, respiratory failure, septic shock on Sep 10, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 217.4 lb, . Pentostatin dosage: 16 Mg.

5413327-1 | Graft Versus Host Disease, Pain
Adverse event was reported on Aug 06, 2007 by a Male patient taking Pentostatin (View Usage) (Dosage: ) was diagnosed with graft versus host disease and. Location: UNITED STATES , weighting 140.9 lb, Patient had the following side effects: graft versus host disease, pain (What is pain?). During the same period patient was treated with CSA (View Csa Review and Csa Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

5409030-4 | Pain
on Jul 20, 2007 Male patient from UNITED STATES , weighting 140.9 lb, was diagnosed with graft versus host disease and was treated with Pentostatin (View Usage). After Pentostatin was administered, patient had the following side effects: pain (What is pain?). Pentostatin dosage: . During the same period patient was treated with CSA (View Csa Review and Csa Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5399141-4 | Aspiration, Chest Pain, Hypotension, Lung Infiltration, Pneumonia, Pseudomonal Bacteraemia, Renal Failure, Urine Output Decreased
on Jul 25, 2007 Male patient from UNITED STATES , weighting 177.5 lb, was treated with Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, chest pain (What is chest pain?), hypotension, lung infiltration, pneumonia (What is pneumonia?), pseudomonal bacteraemia, renal failure, urine output decreased. Pentostatin dosage: 16 Mg. Patient was hospitalized.

5390897-3 | Cough, Dyspnoea, Hypoxia, Pleural Effusion
Patient was taking Pentostatin (View Usage). Patient had the following side effects: cough, dyspnoea, hypoxia, pleural effusion on Jul 05, 2007 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 150.0 lb, . Pentostatin dosage: 7.24 Mg 3/wk Iv. During the same period patient was treated with CYTOXAN (108 Mg 3/wk Iv) (View Cytoxan Review and Cytoxan Label ), RITUXAN (678 Mg 3/wk Iv) (View Rituxan Review and Rituxan Label ), COMPAZINE /00013302/ (View Compazine /00013302/ Review and Compazine /00013302/ Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LIPITOR /01326101/. MFR: NOT SPECIFIED (View Lipitor /01326101/. Mfr: Not Specified Review and Lipitor /01326101/. Mfr: Not Specified Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ASA. MFR: NOT SPECIFIED (View Asa. Mfr: Not Specified Review and Asa. Mfr: Not Specified Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

5331788-3 | Abdominal Pain, Cough, Diarrhoea, Headache, Lung Consolidation, Pericardial Effusion, Pleural Effusion, Pulmonary Alveolar Haemorrhage, Pulmonary Oedema
Adverse event was reported on May 04, 2007 by a Female patient taking Pentostatin (View Usage) (Dosage: 14 Mg Freq Iv) was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Location: UNITED STATES , 43 years of age, weighting 191.8 lb, After Pentostatin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cough, diarrhoea, headache (What is headache?), lung consolidation, pericardial effusion, pleural effusion, pulmonary alveolar haemorrhage, pulmonary oedema. Patient was hospitalized.

5321929-6 | Abdominal Pain, Cough, Diarrhoea, Headache, Pulmonary Alveolar Haemorrhage, Pyrexia, Respiratory Distress, Respiratory Failure
on May 08, 2007 Female patient from UNITED STATES , weighting 191.8 lb, was treated with Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), cough, diarrhoea, headache (What is headache?), pulmonary alveolar haemorrhage, pyrexia, respiratory distress, respiratory failure. Pentostatin dosage: 14 Mg. Patient was hospitalized.

5318570-8 | Abdominal Pain, Cough, Diarrhoea, Headache, Pulmonary Alveolar Haemorrhage, Pyrexia, Respiratory Distress, Respiratory Failure
on May 04, 2007 Female patient from UNITED STATES , weighting 191.8 lb, was treated with Pentostatin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), cough, diarrhoea, headache (What is headache?), pulmonary alveolar haemorrhage, pyrexia, respiratory distress, respiratory failure. Pentostatin dosage: 14 Mg. Patient was hospitalized.

5313394-X | Anorexia, Dehydration, Diarrhoea, Frequent Bowel Movements, Pneumatosis, Refusal Of Treatment By Patient, Treatment Noncompliance
Patient was taking Pentostatin (View Usage). After Pentostatin was administered, patient had the following side effects: anorexia, dehydration, diarrhoea, frequent bowel movements, pneumatosis, refusal of treatment by patient, treatment noncompliance on Apr 27, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 152.1 lb, . Pentostatin dosage: 7.8 Mg. Patient was hospitalized.

5313392-6 | Gun Shot Wound, Head Injury, Intentional Self-injury
Adverse event was reported on Apr 27, 2007 by a Male patient taking Pentostatin (View Usage) (Dosage: 4 Mg) . Location: UNITED STATES , weighting 190.7 lb, Patient experienced the following unwanted or unexpected effects: gun shot wound, head injury, intentional self-injury.

5313389-6 | Anorexia, Diarrhoea, Frequent Bowel Movements, Treatment Noncompliance
on Apr 27, 2007 Male patient from UNITED STATES , weighting 151.2 lb, was treated with Pentostatin (View Usage). Patient had the following side effects: anorexia, diarrhoea, frequent bowel movements, treatment noncompliance. Pentostatin dosage: 7.8 Mg.

5307701-1 | Anaphylactic Reaction, Pyrexia, Transfusion Reaction
on Apr 03, 2007 Male patient from UNITED STATES , 69 years of age, weighting 151.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Pentostatin (View Usage). After Pentostatin was administered, patient had the following side effects: anaphylactic reaction, pyrexia, transfusion reaction. Pentostatin dosage: 7.24 Mg Q3w Iv. During the same period patient was treated with CYTOXAN (108 Mg Q3w Iv) (View Cytoxan Review and Cytoxan Label ), RITUXAN (672 Mg Q3w Iv) (View Rituxan Review and Rituxan Label ), COMPAZINE /00013302/ (View Compazine /00013302/ Review and Compazine /00013302/ Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LIPITOR /01326101/. MFR: NOT SPECIFIED (View Lipitor /01326101/. Mfr: Not Specified Review and Lipitor /01326101/. Mfr: Not Specified Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ASA. MFR: NOT SPECIFIED (View Asa. Mfr: Not Specified Review and Asa. Mfr: Not Specified Label ), NIACIN (View Niacin Review and Niacin Label ). Patient was hospitalized.

5288027-1 | Ascites, Bacterial Infection, Cholangitis, Cholecystitis, Hepatic Failure, Hepatitis, Hypotension, Lung Neoplasm, Pancreatitis
Patient was taking Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, bacterial infection (What is bacterial infection?), cholangitis, cholecystitis, hepatic failure, hepatitis (What is hepatitis?), hypotension, lung neoplasm, pancreatitis on Mar 20, 2007 from UNITED STATES Additional patient health information: Female patient , child 11 years of age, weighting 52.91 lb, was diagnosed with graft versus host disease and. Pentostatin dosage: 4 Mg/m2 Fortnightly Iv. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), OXYCODONE HCL EXTENDED RELEASE (View Oxycodone Hcl Extended-release Review and Oxycodone Hcl Extended-release Label ), METRONIDAZOLE ORAL SUSPENSION (View Metronidazole Oral Suspension Review and Metronidazole Oral Suspension Label ), SULFAMETHOXAZOLE + TRIMETHOPRIM (View Sulfamethoxazole + Trimethoprim Review and Sulfamethoxazole + Trimethoprim Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), BECLOMETHASONE AQUEOUS (View Beclomethasone Aqueous Review and Beclomethasone Aqueous Label ). Patient was hospitalized.

5270829-9 | Dialysis, Dyspnoea, Hypophosphataemia, Renal Failure, Thrombotic Microangiopathy
Adverse event was reported on Mar 19, 2007 by a Male patient taking Pentostatin (View Usage) (Dosage: 8mg X1 Iv Bolus) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , weighting 185.0 lb, Patient had the following side effects: dialysis (What is dialysis?), dyspnoea, hypophosphataemia, renal failure, thrombotic microangiopathy. During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), RITUXAN (View Rituxan Review and Rituxan Label ), PALONOSETRON (View Palonosetron Review and Palonosetron Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FAMVIR (View Famvir Review and Famvir Label ). Patient was hospitalized.

5257144-4 | Convulsion, Diarrhoea, Eating Disorder, Overdose, Progressive Multifocal Leukoencephalopathy, Sepsis
on Feb 22, 2007 Male patient from UNITED STATES , child 9 years of age, weighting 55.12 lb, was diagnosed with graft versus host disease and was treated with Pentostatin (View Usage). After Pentostatin was administered, patient had the following side effects: convulsion, diarrhoea, eating disorder (What is eating disorder?), overdose, progressive multifocal leukoencephalopathy, sepsis (What is sepsis?). Pentostatin dosage: 4 Mg/m2 Fortnightly Iv. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), ATROPINE (View Atropine Review and Atropine Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ZOFRAN (View Zofran Review and Zofran Label ), ATIVAN (View Ativan Review and Ativan Label ), METHYLPHENIDATE HCL (View Methylphenidate Hcl Review and Methylphenidate Hcl Label ).

5242445-6 | Bacteraemia, Neutropenia, Pneumonia, Pneumonia Necrotising, Serratia Infection
on Feb 08, 2007 Male patient from UNITED STATES , 25 years of age, was diagnosed with large granular lymphocytosis and was treated with Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, neutropenia, pneumonia (What is pneumonia?), pneumonia necrotising, serratia infection. Pentostatin dosage: 4 Mg/m2 Weekly Iv. During the same period patient was treated with CAMPATH (3 Mg Per_cycle Iv) (View Campath Review and Campath Label ), MORPHINE (View Morphine Review and Morphine Label ), VALTREX (View Valtrex Review and Valtrex Label ), FLAGYL /00012501/. MFR: NOT SPECIFIED (View Flagyl /00012501/. Mfr: Not Specified Review and Flagyl /00012501/. Mfr: Not Specified Label ), BACTRIM /00086101/. MFR: NOT SPECIFIED (View Bactrim /00086101/. Mfr: Not Specified Review and Bactrim /00086101/. Mfr: Not Specified Label ). Patient was hospitalized.

5242045-8 | Bacteraemia, Neutropenia, Pneumonia Necrotising, Serratia Infection
Patient was taking Pentostatin (View Usage). Patient had the following side effects: bacteraemia, neutropenia, pneumonia necrotising, serratia infection on Jan 31, 2007 from UNITED STATES Additional patient health information: Male patient , 25 years of age, was diagnosed with large granular lymphocytosis and. Pentostatin dosage: 4 Mg/m2 Weekly Iv. During the same period patient was treated with CAMPATH (3 Mg Per_cycle Iv) (View Campath Review and Campath Label ), MORPHINE (View Morphine Review and Morphine Label ), VALTREX (View Valtrex Review and Valtrex Label ), FLAGYL (View Flagyl Review and Flagyl Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

5233384-5 | Acute Graft Versus Host Disease In Liver, Diarrhoea, Escherichia Sepsis
Adverse event was reported on Jan 25, 2007 by a Male patient taking Pentostatin (View Usage) (Dosage: 4 Mg/m2 Fortnightly Iv) was diagnosed with chronic graft versus host disease and. Location: UNITED STATES , child 9 years of age, weighting 59.08 lb, After Pentostatin was administered, patient had the following side effects: acute graft versus host disease in liver, diarrhoea, escherichia sepsis. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), CALCIUM PHOSPHATE (View Calcium Phosphate Review and Calcium Phosphate Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DAPSONE (View Dapsone Review and Dapsone Label ). Patient was hospitalized.

5229272-0 | Acute Respiratory Distress Syndrome, Anaemia, Diffuse Alveolar Damage, Hyperglycaemia, Hypernatraemia, Hypotension, Malnutrition, Pneumonia, Respiratory Acidosis
on Jan 26, 2007 Female patient from UNITED STATES , 49 years of age, was diagnosed with t-cell prolymphocytic leukaemia and was treated with Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, anaemia, diffuse alveolar damage, hyperglycaemia, hypernatraemia, hypotension, malnutrition, pneumonia (What is pneumonia?), respiratory acidosis. Pentostatin dosage: 6.24 Mg Weekly Iv. During the same period patient was treated with CAMPATH (30 Mg 3/wk Iv) (View Campath Review and Campath Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), LO/OVRAL (View Lo/ovral Review and Lo/ovral Label ), ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ). Patient was hospitalized.

5227368-0 | Acute Respiratory Distress Syndrome, Anaemia, Catheter Site Haematoma, Hyperglycaemia, Hypernatraemia, Hypotension, Iatrogenic Injury, Malnutrition
on Jan 23, 2007 Female patient from UNITED STATES , 49 years of age, was diagnosed with prolymphocytic leukaemia and was treated with Pentostatin (View Usage). Patient had the following side effects: acute respiratory distress syndrome, anaemia, catheter site haematoma, hyperglycaemia, hypernatraemia, hypotension, iatrogenic injury, malnutrition. Pentostatin dosage: 6.24 Mg Weekly Iv. During the same period patient was treated with CAMPATH (30 Mg 3/wk Iv) (View Campath Review and Campath Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), LO/OVRAL (View Lo/ovral Review and Lo/ovral Label ), ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ). Patient was hospitalized.

5218764-6 | Pneumonia, Pulmonary Alveolar Haemorrhage, Respiratory Failure, Respiratory Syncytial Virus Infection
Patient was taking Pentostatin (View Usage). After Pentostatin was administered, patient had the following side effects: pneumonia (What is pneumonia?), pulmonary alveolar haemorrhage, respiratory failure, respiratory syncytial virus infection (What is respiratory syncytial virus infection?) on Jan 11, 2007 from UNITED STATES Additional patient health information: Female patient , 49 years of age, was diagnosed with t-cell prolymphocytic leukaemia and. Pentostatin dosage: 6.24 Mg Weekly Iv. During the same period patient was treated with CAMPATH (30 Mg 3wk Iv) (View Campath Review and Campath Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), LO/OVRAL (View Lo/ovral Review and Lo/ovral Label ), ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ). Patient was hospitalized.

5209171-0 | Blood Potassium Increased, Chronic Obstructive Pulmonary Disease, Haemolytic Anaemia, Ischaemic Cardiomyopathy, Renal Failure, Upper Gastrointestinal Haemorrhage
Adverse event was reported on Jan 03, 2007 by a Male patient taking Pentostatin (View Usage) (Dosage: 8 Mg Q3w Iv) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: blood potassium increased, chronic obstructive pulmonary disease, haemolytic anaemia, ischaemic cardiomyopathy, renal failure, upper gastrointestinal haemorrhage. During the same period patient was treated with CYTOXAN (1200 Mg Q3w Iv) (View Cytoxan Review and Cytoxan Label ), RITUXAN (750 Mg Q3w Iv) (View Rituxan Review and Rituxan Label ), ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ), SEPTRA DS (View Septra Ds Review and Septra Ds Label ), VALTREX (View Valtrex Review and Valtrex Label ), BENADRYL (View Benadryl Review and Benadryl Label ), DECADRON (View Decadron Review and Decadron Label ), KYTRIL (View Kytril Review and Kytril Label ). Patient was hospitalized.

5186946-8 | Blood Potassium Increased, Haemolytic Anaemia, Ischaemic Cardiomyopathy, Renal Failure, Upper Gastrointestinal Haemorrhage
on Dec 01, 2006 Male patient from UNITED STATES , 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Pentostatin (View Usage). Patient had the following side effects: blood potassium increased, haemolytic anaemia, ischaemic cardiomyopathy, renal failure, upper gastrointestinal haemorrhage. Pentostatin dosage: 8 Mg Q3w Iv. During the same period patient was treated with CYTOXAN (1200 Mg Q3w Iv) (View Cytoxan Review and Cytoxan Label ), RITUXAN (750 Mg Q3w Iv) (View Rituxan Review and Rituxan Label ), ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ), SEPTRA DS (View Septra Ds Review and Septra Ds Label ), VALTREX (View Valtrex Review and Valtrex Label ), BENADRYL /00000402/ (View Benadryl /00000402/ Review and Benadryl /00000402/ Label ), DECADRON (View Decadron Review and Decadron Label ), KYTRIL /01178101/ (View Kytril /01178101/ Review and Kytril /01178101/ Label ). Patient was hospitalized.

5179191-3 | Blood Potassium Increased, Faeces Discoloured, Haemolytic Anaemia, Ischaemic Cardiomyopathy, Renal Failure, Upper Gastrointestinal Haemorrhage
on Dec 01, 2006 Male patient from UNITED STATES , 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Pentostatin (View Usage). After Pentostatin was administered, patient had the following side effects: blood potassium increased, faeces discoloured, haemolytic anaemia, ischaemic cardiomyopathy, renal failure, upper gastrointestinal haemorrhage. Pentostatin dosage: 8 Mg Q3w Iv. During the same period patient was treated with CYTOXAN (1200 Mg Q3w Iv) (View Cytoxan Review and Cytoxan Label ), RITUXAN (750 Mg Q3w Iv) (View Rituxan Review and Rituxan Label ), ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ), SEPTRA DS (View Septra Ds Review and Septra Ds Label ), VALTREX (View Valtrex Review and Valtrex Label ), BENADRYL /00000402/ (View Benadryl /00000402/ Review and Benadryl /00000402/ Label ), DECADRON (View Decadron Review and Decadron Label ), KYTRIL (View Kytril Review and Kytril Label ). Patient was hospitalized.

4879029-5 | Aspergillosis, Blood Blister, Computerised Tomogram Abnormal, Lung Disorder, Petechiae, Productive Cough, Pyrexia, Sputum Discoloured
Patient was taking Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: aspergillosis, blood blister, computerised tomogram abnormal, lung disorder, petechiae, productive cough, pyrexia, sputum discoloured on Jan 10, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 179.2 lb, was diagnosed with chronic lymphocytic leukaemia and. Pentostatin dosage: See Image. During the same period patient was treated with RITUXAN (See Image) (View Rituxan Review and Rituxan Label ), CYTOXAN (See Image) (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

4872506-2 | Blood Blister, Body Temperature Increased, Oral Mucosal Blistering, Petechiae, Sputum Discoloured
Adverse event was reported on Dec 30, 2005 by a Male patient taking Pentostatin (View Usage) (Dosage: See Image) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , weighting 179.2 lb, Patient had the following side effects: blood blister, body temperature increased, oral mucosal blistering, petechiae, sputum discoloured. During the same period patient was treated with RITUXAN (See Image) (View Rituxan Review and Rituxan Label ), CYTOXAN (See Image) (View Cytoxan Review and Cytoxan Label ). Patient was hospitalized.

4829945-5 | Renal Failure Acute
on Nov 15, 2005 Male patient from UNITED STATES , 75 years of age, weighting 187.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Pentostatin (View Usage). After Pentostatin was administered, patient had the following side effects: renal failure acute. Pentostatin dosage: 4 Mg/m2 Iv Q 3 Weeks. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), EPOETIN ALFA RECOMB (View Epoetin Alfa Recomb Review and Epoetin Alfa Recomb Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), TYLENOL W/ CODEINE NO. 3 (View Tylenol W/ Codeine No. 3 Review and Tylenol W/ Codeine No. 3 Label ), BENADRYL (View Benadryl Review and Benadryl Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

4799815-X | Dysphagia, Oral Intake Reduced, Stomatitis
on Oct 11, 2005 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with neoplasm malignant and was treated with Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, oral intake reduced, stomatitis. Pentostatin dosage: [prior To Admission]. During the same period patient was treated with LOPRESSOR (View Lopressor Review and Lopressor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4771508-4 | Asthenia, Diarrhoea, Dizziness Postural, Frequent Bowel Movements, Graft Versus Host Disease, Haematochezia, Oral Intake Reduced
Patient was taking Pentostatin (View Usage). Patient had the following side effects: asthenia, diarrhoea, dizziness postural, frequent bowel movements, graft versus host disease, haematochezia, oral intake reduced on Sep 14, 2005 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with graft versus host disease and. Pentostatin dosage: 4mg/m2/d Qd Iv.

4727099-7 | Renal Failure Acute, Urine Output Decreased
Adverse event was reported on Jul 26, 2005 by a Female patient taking Pentostatin (View Usage) (Dosage: See Image) was diagnosed with graft versus host disease and. Location: UNITED STATES , weighting 131.0 lb, After Pentostatin was administered, patient had the following side effects: renal failure acute, urine output decreased. Patient was hospitalized.

4724657-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cholelithiasis, Confusional State, Diabetes Mellitus Inadequate Control, Disease Progression, Disorientation
on Jul 19, 2005 Male patient from UNITED STATES , weighting 207.2 lb, was diagnosed with graft versus host disease and was treated with Pentostatin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cholelithiasis, confusional state, diabetes mellitus inadequate control, disease progression, disorientation. Pentostatin dosage: See Image. Patient was hospitalized.

4712803-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Biopsy Liver Abnormal, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Cholelithiasis, Diabetes Mellitus Inadequate Control
on Jul 08, 2005 Male patient from UNITED STATES , weighting 207.2 lb, was diagnosed with graft versus host disease and was treated with Pentostatin (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biopsy liver abnormal, blood alkaline phosphatase increased, blood bilirubin increased, cholelithiasis, diabetes mellitus inadequate control. Pentostatin dosage: 4mg/m2 Iv Over 20-30 Minutes Every 2 Weeks Patient Received 1 Course 6/10/05 And A 2nd On 6/24/05. Patient was hospitalized.

4697972-7 | Biopsy Liver Abnormal, Blood Bilirubin Increased, Blood Glucose Fluctuation, Cholelithiasis, Graft Versus Host Disease
Patient was taking Pentostatin (View Usage). After Pentostatin was administered, patient had the following side effects: biopsy liver abnormal, blood bilirubin increased, blood glucose fluctuation, cholelithiasis, graft versus host disease on Jun 22, 2005 from Additional patient health information: Male patient , weighting 207.2 lb, was diagnosed with graft versus host disease and. Pentostatin dosage: 4 Mg/m2 Iv Over 20-30 Minutes Every 2 Weeks.

4622749-8 | Condition Aggravated, Deep Vein Thrombosis, Disseminated Intravascular Coagulation, Lobar Pneumonia, Respiratory Distress, Thrombocytopenia
Adverse event was reported on Mar 29, 2005 by a Female patient taking Pentostatin (View Usage) (Dosage: 2 Mg/m2 (dose Reduced Due To Decreaed Creatinine Clearance)) . Location: , weighting 179.9 lb, Patient experienced the following unwanted or unexpected effects: condition aggravated, deep vein thrombosis (What is deep vein thrombosis?), disseminated intravascular coagulation, lobar pneumonia, respiratory distress, thrombocytopenia.